Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

425 ARTÍCULOS , VIENDO DEL 211 AL 225

An overview of glutaminyl cyclase inhibitors for Alzheimer's disease

Coimbra JR, Sobral PJ, Santos AE, Moreira PI, Salvador JA.

Future Med Chem. 2019 Dec;11(24):3179-3194. doi: 10.4155/fmc-2019-0163.

[The Convergence of Alzheimer's Disease Pathogenesis Concepts]

Kozin SA, Makarov AA.

Mol Biol (Mosk). 2019 Nov-Dec;53(6):1020-1028. doi: 10.1134/S0026898419060107.

Mitochondrial Dysfunction and Alpha-Lipoic Acid: Beneficial or Harmful in Alzheimer's Disease?

Dos Santos SM, Romeiro CFR, Rodrigues CA, Cerqueira ARL, Monteiro MC.

Oxid Med Cell Longev. 2019 Nov 30;2019:8409329. doi: 10.1155/2019/8409329. eCollection 2019.

Alzheimer's Disease Pharmacotherapy in Relation to Cholinergic System Involvement

Stanciu GD, Luca A, Rusu RN, Bild V, Beschea Chiriac SI, Solcan C, Bild W, Ababei DC.

Biomolecules. 2019 Dec 26;10(1):40. doi: 10.3390/biom10010040.

Therapeutic Study of Phytochemicals Against Cancer and Alzheimer's Disease Management

Ahmad SS, Waheed T, Rozeen S, Mahmood S, Kamal MA.

Curr Drug Metab. 2019;20(13):1006-1013. doi: 10.2174/1389200221666200103092719.

Neuroprotective Effects of Quercetin in Alzheimer's Disease

Khan H, Ullah H, Aschner M, Cheang WS, Akkol EK.

Biomolecules. 2019 Dec 30;10(1):59. doi: 10.3390/biom10010059.

Challenges in the Discovery of Novel Therapeutic Agents in Cancer

Nagaraju GP, Kamal MA.

Curr Drug Metab. 2019;20(13):1004-1005. doi: 10.2174/138920022013200123122311.

Pharmacokinetics and Pharmacodynamics of the BACE1 Inhibitor Verubecestat (MK-8931) in Healthy Japanese Adults: A Randomized, Placebo-Controlled Study

Chris Min K, Dockendorf MF, Palcza J, Tseng J, Ma L, Stone JA, Kleijn HJ, Hodsman P, Masuo K, Tanen M, Troyer MD, van Vugt M, Forman MS.

Clin Pharmacol Ther. 2019 May;105(5):1234-1243. doi: 10.1002/cpt.1258. Epub 2019 Jan 18.

Sex differences of brain and their implications for personalized therapy

Rezzani R, Franco C, Rodella LF.

Pharmacol Res. 2019 Mar;141:429-442. doi: 10.1016/j.phrs.2019.01.030. Epub 2019 Jan 16.

Transethnic meta-analysis of rare coding variants in PLCG2, ABI3, and TREM2 supports their general contribution to Alzheimer's disease

Dalmasso MC, Brusco LI, Olivar N, Muchnik C, Hanses C, Milz E, Becker J, Heilmann-Heimbach S, Hoffmann P, Prestia FA, Galeano P, Avalos MSS, Martinez LE, Carulla ME, Azurmendi PJ, Liberczuk C, Fezza C, Sampaño M, Fierens M, Jemar G, Solis P, Medel N, Lisso J, Sevillano Z, Bosco P, Bossù P, Spalletta G, Galimberti D, Mancuso M, Nacmias B, Sorbi S, Mecocci P, Pilotto A, Caffarra P, Panza F, Bullido M, Clarimon J, Sánchez-Juan P, Coto E, Sanchez-Garcia F, Graff C, Ingelsson M, Bellenguez C, Castaño EM, Kairiyama C, Politis DG, Kochen S, Scaro H, Maier W, Jessen F, Mangone CA, Lambert JC, Morelli L, Ramirez A.

Transl Psychiatry. 2019 Jan 31;9(1):55. doi: 10.1038/s41398-019-0394-9.

Early life exposure to lead (Pb) and changes in DNA methylation: relevance to Alzheimer's disease

Bihaqi SW.

Rev Environ Health. 2019 Jun 26;34(2):187-195. doi: 10.1515/reveh-2018-0076.

Avoiding Alzheimer's disease: The important causative role of divalent copper ingestion

Brewer GJ.

Exp Biol Med (Maywood). 2019 Feb;244(2):114-119. doi: 10.1177/1535370219827907. Epub 2019 Feb 6.

Insights into the Potential Role of Mercury in Alzheimer's Disease

Bjørklund G, Tinkov AA, Dadar M, Rahman MM, Chirumbolo S, Skalny AV, Skalnaya MG, Haley BE, Ajsuvakova OP, Aaseth J.

J Mol Neurosci. 2019 Apr;67(4):511-533. doi: 10.1007/s12031-019-01274-3. Epub 2019 Mar 15.

A 48-Week, Multicenter, Open-Label, Observational Study Evaluating Oral Rivastigmine in Patients with Mild-to-Moderate Alzheimer's Disease in Taiwan

Chang CC, Peng GS, Lai TJ, Li CH, Liu CK.

Adv Ther. 2019 Jun;36(6):1455-1464. doi: 10.1007/s12325-019-00939-0. Epub 2019 Apr 5.

Mediterranean and MIND Diets Containing Olive Biophenols Reduces the Prevalence of Alzheimer's Disease

Omar SH.

Int J Mol Sci. 2019 Jun 7;20(11):2797. doi: 10.3390/ijms20112797.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias